Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden
· Delayed Price · Currency is SEK 6.08
+0.18 (3.09%)
Mar 10, 2026, 9:19 AM CET
Xbrane Biopharma AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 127.24 | -266.22 | -388.17 | -172.51 | -188.38 | Upgrade
|
| Depreciation & Amortization | 14.6 | 24.21 | 21.43 | 16.58 | 12.22 | Upgrade
|
| Other Operating Activities | -316.17 | 67.22 | 145.36 | -7.25 | -5.04 | Upgrade
|
| Change in Accounts Receivable | 70.03 | -4.56 | -85.13 | 1.7 | -61.09 | Upgrade
|
| Change in Inventory | 48.98 | -166 | -56.6 | -50.26 | - | Upgrade
|
| Change in Accounts Payable | - | 212.82 | 22.57 | - | - | Upgrade
|
| Change in Other Net Operating Assets | -368.78 | - | - | 17.83 | 22.67 | Upgrade
|
| Operating Cash Flow | -250.69 | -133.73 | -406.68 | -193.92 | -219.61 | Upgrade
|
| Capital Expenditures | - | -0.5 | -6.79 | -11.62 | -27.68 | Upgrade
|
| Sale (Purchase) of Intangibles | -139.64 | -51.75 | -9.98 | -48.51 | -49.67 | Upgrade
|
| Other Investing Activities | 102.5 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -37.14 | -52.25 | -16.77 | -60.13 | -77.35 | Upgrade
|
| Long-Term Debt Issued | 77.6 | 70 | 225 | - | - | Upgrade
|
| Long-Term Debt Repaid | -47.78 | -126.14 | -34.74 | -8.34 | -7.27 | Upgrade
|
| Total Debt Repaid | -47.78 | -126.14 | -34.74 | -8.34 | -7.27 | Upgrade
|
| Net Debt Issued (Repaid) | 29.82 | -56.14 | 190.26 | -8.34 | -7.27 | Upgrade
|
| Issuance of Common Stock | 240 | 337.24 | 120.02 | 170.55 | 380.87 | Upgrade
|
| Other Financing Activities | -14.22 | -37.48 | -11.58 | -13.35 | -24.23 | Upgrade
|
| Financing Cash Flow | 255.61 | 243.62 | 298.7 | 148.86 | 349.37 | Upgrade
|
| Foreign Exchange Rate Adjustments | -6.05 | 0.84 | -4.49 | 4.05 | 1.39 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0.53 | 0.44 | 0.64 | -0.05 | -1.76 | Upgrade
|
| Net Cash Flow | -37.74 | 58.93 | -128.59 | -101.19 | 52.04 | Upgrade
|
| Free Cash Flow | -250.69 | -134.23 | -413.47 | -205.53 | -247.29 | Upgrade
|
| Free Cash Flow Margin | -164.55% | -67.55% | -173.20% | -356.72% | -2309.16% | Upgrade
|
| Free Cash Flow Per Share | -20.59 | -13.64 | -1800.48 | -1004.76 | -1310.16 | Upgrade
|
| Cash Interest Paid | - | 17.65 | 7.58 | 2.59 | 2.64 | Upgrade
|
| Cash Income Tax Paid | 2.23 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | -348.98 | -67 | -244 | -169.78 | -279.72 | Upgrade
|
| Unlevered Free Cash Flow | -339.18 | -45.98 | -232.43 | -168.17 | -278.07 | Upgrade
|
| Change in Working Capital | -249.77 | 42.27 | -119.16 | -30.73 | -38.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.